Enlivex ENLV
NASDAQ ENLV
$0.48 +0.00 (+0.04%)
As of: Sep 30, 2026 · 9:57 AM EDT

Enlivex (ENLV) Current Debt (2015 - 2024)

Updated

Enlivex (ENLV) reported Current Debt of $836,000 for Q3 2024, up 719.6% from $102,000 a year earlier and up 727.7% from the prior quarter.

Analysis

Enlivex (ENLV) Current Debt (2015 - 2024) Analysis & Trends

Over the twelve months ended Sep 30, 2024, Enlivex's Current Debt came in at $1.1 million, down 38.8% year-over-year; for FY2017, it was $3 million, down 40.1% from FY2016.

  • By year, Current Debt came in at $5.01 million in FY2016 (-49.9%) and $10 million in FY2015.
  • The Q3 2024 figure ranks as the highest quarterly Current Debt since Q1 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Debt (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn -
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 208.00 Mn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 37.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 64.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Enlivex 1.58 Mn -54.81 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 836,000.00
Jun 30, 2024 101,000.00
Mar 31, 2024 65,000.00
Sep 30, 2023 102,000.00
Jun 30, 2023 234,000.00
Mar 31, 2023 1.39 Mn
Jun 30, 2016 76,000.00
Jun 30, 2015 -31,000.00
API Access

Enlivex Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=ENLV&period=max&api_key=YOUR_API_KEY